Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M76.6Revenue $M0Net Margin (%)0Z-Score30.5
Enterprise Value $M48.4EPS $-0.1Operating Margin %0F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book2.410-y EBITDA Growth Rate %0Quick Ratio20.8Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %0Current Ratio20.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-52.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-54.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M247ROI % (ttm)-111.7Gross Margin Increase y-yN

Gurus Latest Trades with ONCS

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ONCS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ONCS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MAIDA ANTHONY E IIIDirector 2014-03-20Buy22,800$0.81-61.73 view
DHILLON PUNITPresident and CEO 2014-03-19Buy50,000$0.8-61.25 view

Press Releases about ONCS :

    Quarterly/Annual Reports about ONCS:

    News about ONCS:

    Articles On GuruFocus.com
    Vista Partners Initiates Coverage on OncoSec Medical (Ticker: ONCS); Price Target $1.20 Jan 13 2015 
    Portfolio 1 Jan 03 2015 

    More From Other Websites
    Heat Biologics is an Opportunity Among Soaring Immunotherapy Biotech Valuations Apr 14 2015
    Vista Partners Publishes April 2015 Macroeconomic & Investment Newsletter Apr 08 2015
    OncoSec Medical to Present at Needham & Company’s 14th Annual Healthcare Conference Apr 02 2015
    OncoSec Medical to Present at Needham & Company’s 14th Annual Healthcare Conference Apr 02 2015
    ONCOSEC MEDICAL INC Financials Mar 19 2015
    OncoSec Medical CEO Punit Dhillon to Host Live Webinar to Provide Corporate Update and 2015 Outlook Mar 17 2015
    OncoSec Medical CEO Punit Dhillon to Host Live Webinar to Provide Corporate Update and 2015 Outlook Mar 17 2015
    ONCOSEC MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 12 2015
    OncoSec Medical Announces Six Months Results for Fiscal Year End 2015 Mar 12 2015
    OncoSec Medical Announces Six Months Results for Fiscal Year End 2015 Mar 12 2015
    ONCOSEC MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Mar 11 2015
    Heat Biologics' Bladder Cancer Drug Gets Fast Track Status - Analyst Blog Mar 10 2015
    CORRECTING and REPLACING OncoSec Medical to Present at Prominent Scientific and Investment... Mar 04 2015
    CORRECTING and REPLACING OncoSec Medical to Present at Prominent Scientific and Investment... Mar 04 2015
    OncoSec Medical to Present at Prominent Scientific and Investment Conferences in March Mar 04 2015
    Heat Biologics Up on Immune-Oncology Deal with OncoSec - Analyst Blog Feb 19 2015
    Heat Biologics, Inc. and OncoSec Medical Inc. Announce Collaboration to Evaluate Combination of... Feb 18 2015
    OncoSec Medical Inc. and Heat Biologics, Inc. Announce Collaboration to Evaluate Combination of... Feb 18 2015
    OncoSec Medical Inc. and Heat Biologics, Inc. Announce Collaboration to Evaluate Combination of... Feb 18 2015
    OncoSec Medical to Present at Two Events in February Feb 03 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK